Wall Street brokerages expect Medical Properties Trust, Inc. (NYSE:MPW) to post $203.65 million in sales for the current fiscal quarter, Zacks reports. Eight analysts have provided estimates for Medical Properties Trust’s earnings, with the highest sales estimate coming in at $220.84 million and the lowest estimate coming in at $187.23 million. Medical Properties Trust reported sales of $197.00 million in the same quarter last year, which indicates a positive year-over-year growth rate of 3.4%. The business is expected to report its next quarterly earnings report on Thursday, November 7th.
According to Zacks, analysts expect that Medical Properties Trust will report full-year sales of $801.25 million for the current year, with estimates ranging from $744.68 million to $852.52 million. For the next fiscal year, analysts anticipate that the business will report sales of $938.30 million, with estimates ranging from $667.76 million to $1.18 billion. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow Medical Properties Trust.
Medical Properties Trust (NYSE:MPW) last issued its earnings results on Thursday, August 1st. The real estate investment trust reported $0.31 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.31. The firm had revenue of $192.55 million for the quarter, compared to analyst estimates of $186.11 million. Medical Properties Trust had a return on equity of 6.84% and a net margin of 129.20%. The business’s revenue was down 4.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.36 earnings per share.
Shares of NYSE:MPW traded down $0.05 during midday trading on Thursday, reaching $20.24. 4,078,798 shares of the company traded hands, compared to its average volume of 3,739,861. The company has a quick ratio of 8.00, a current ratio of 8.00 and a debt-to-equity ratio of 0.99. Medical Properties Trust has a 12 month low of $14.46 and a 12 month high of $20.44. The firm has a market capitalization of $9.06 billion, a price-to-earnings ratio of 14.77, a price-to-earnings-growth ratio of 4.08 and a beta of 0.53. The firm’s fifty day moving average price is $19.34 and its two-hundred day moving average price is $18.36.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 10th. Stockholders of record on Thursday, September 12th were issued a $0.26 dividend. This is a boost from Medical Properties Trust’s previous quarterly dividend of $0.25. This represents a $1.04 dividend on an annualized basis and a dividend yield of 5.14%. The ex-dividend date was Wednesday, September 11th. Medical Properties Trust’s dividend payout ratio is presently 75.91%.
In other news, CEO Edward K. Aldag, Jr. sold 101,964 shares of the business’s stock in a transaction dated Thursday, October 10th. The stock was sold at an average price of $19.78, for a total value of $2,016,847.92. Following the completion of the sale, the chief executive officer now owns 2,058,820 shares of the company’s stock, valued at approximately $40,723,459.60. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Emmett E. Mclean sold 100,000 shares of the business’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $18.37, for a total value of $1,837,000.00. Following the completion of the sale, the insider now directly owns 1,066,337 shares of the company’s stock, valued at approximately $19,588,610.69. The disclosure for this sale can be found here. In the last three months, insiders sold 349,464 shares of company stock valued at $6,603,573. 1.18% of the stock is currently owned by corporate insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. First Trust Advisors LP raised its position in Medical Properties Trust by 30.2% during the 1st quarter. First Trust Advisors LP now owns 1,180,023 shares of the real estate investment trust’s stock valued at $21,842,000 after purchasing an additional 273,483 shares during the last quarter. Marshall Wace LLP bought a new position in Medical Properties Trust during the 1st quarter valued at approximately $148,000. Marshall Wace North America L.P. bought a new position in Medical Properties Trust during the 1st quarter valued at approximately $120,000. GYL Financial Synergies LLC bought a new position in Medical Properties Trust during the 1st quarter valued at approximately $505,000. Finally, MetLife Investment Advisors LLC raised its position in Medical Properties Trust by 4.4% during the 1st quarter. MetLife Investment Advisors LLC now owns 232,282 shares of the real estate investment trust’s stock valued at $4,300,000 after purchasing an additional 9,756 shares during the last quarter. 71.35% of the stock is owned by institutional investors.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.